Chad J. Kolean
2023
In 2023, Chad J. Kolean earned a total compensation of $1.1M as Chief Financial Officer at Cellectar Biosciences, a 140% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $234,000 |
|---|---|
| Option Awards | $284,960 |
| Salary | $390,000 |
| Stock Awards | $112,770 |
| Other | $87,230 |
| Total | $1,108,960 |
Kolean received $390K in salary, accounting for 35% of the total pay in 2023.
Kolean also received $234K in non-equity incentive plan, $285K in option awards, $112.8K in stock awards and $87.2K in other compensation.
Rankings
In 2023, Chad J. Kolean's compensation ranked 1,069th out of 2,804 executives tracked by ExecPay. In other words, Kolean earned more than 61.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,069 out of 2,804 | 62nd |
Division Manufacturing | 640 out of 1,541 | 59th |
Major group Chemicals And Allied Products | 439 out of 871 | 50th |
Industry group Drugs | 428 out of 834 | 49th |
Industry Pharmaceutical Preparations | 291 out of 599 | 51st |
Source: SEC filing on April 26, 2024.
Kolean's colleagues
We found two more compensation records of executives who worked with Chad J. Kolean at Cellectar Biosciences in 2023.